Who owns Larimar Therapeutics Inc Com stock?
- Ticker: LRMR
- CUSIP Number: 517125100
Tip: Access positions for across all investors
Analyze quarterly positions in Larimar Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Larimar Therapeutics stock
Who bought or sold Larimar Therapeutics Inc Com stock this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 17M | $77M | 0% | Dec 2023 |
|
| Blue Owl Capital Holdings | 3.4M | $16M | 100% | Dec 2023 |
|
| Henderson Group | 2.6M | $12M | 7% | Dec 2023 |
|
| Vanguard Group | 1.5M | $6.6M | 2% | Dec 2023 |
|
| Citadel Advisors | 685k | $3.1M | -30% | Dec 2023 |
|
| Opaleye Management | 624k | $2.8M | -27% | Dec 2023 |
|
| Ikarian Capital | 603k | $2.7M | -12% | Dec 2023 |
|
| Point72 Asset Management | 450k | $2.0M | -1% | Dec 2023 |
|
| DAFNA Capital Management | 324k | $1.5M | -1% | Dec 2023 |
|
| Atlas Venture Advisors | 292k | $1.3M | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 272k | $1.2M | 100% | Dec 2023 |
|
| Dimensional Fund Advisors | 195k | $888k | -13% | Dec 2023 |
|
| Goldman Sachs Group | 134k | $609k | -1% | Dec 2023 |
|
| J. Goldman & Co | 121k | $551k | 124% | Dec 2023 |
|
| Two Sigma Advisers | 109k | $497k | -31% | Dec 2023 |
|
| Bank of New York Mellon | 97k | $440k | -1% | Dec 2023 |
|
| Fred Alger Management | 87k | $394k | -26% | Dec 2023 |
|
| Charles Schwab Investment Management | 74k | $336k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 61k | $275k | 118% | Dec 2023 |
|
| Walleye Trading Advisors | 59k | $266k | -72% | Dec 2023 |
|
| Barclays | 35k | $160k | 602% | Dec 2023 |
|
| Journey Strategic Wealth | 35k | $160k | 0% | Dec 2023 |
|
| Two Sigma Investments | 34k | $155k | -45% | Dec 2023 |
|
| Rhumbline Advisers | 28k | $129k | -2% | Dec 2023 |
|
| UBS Group | 28k | $128k | 100% | Dec 2023 |
|
| Fi3 FINANCIAL ADVISORS | 25k | $116k | 0% | Dec 2023 |
|
| GSA Capital Partners | 25k | $115k | -72% | Dec 2023 |
|
| Bank of America Corporation | 25k | $113k | 45% | Dec 2023 |
|
| Golden State Equity Partners | 25k | $113k | 4% | Dec 2023 |
|
| SG Americas Securities | 14k | $64k | 27% | Dec 2023 |
|
| American International | 13k | $58k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 8.8k | $40k | 28% | Dec 2023 |
|
| Wells Fargo & Company | 8.0k | $36k | 24% | Dec 2023 |
|
| New York State Common Retirement Fund | 6.6k | $30k | -1% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 5.3k | $24k | 0% | Dec 2023 |
|
| Solstein Capital | 4.5k | $20k | 0% | Dec 2023 |
|
| Citigroup | 3.7k | $17k | 19184% | Dec 2023 |
|
| Legal & General Group | 2.5k | $11k | 0% | Dec 2023 |
|
| Amalgamated Bank | 2.2k | $10k | -10% | Dec 2023 |
|
| Summit Investment Advisors | 2.1k | $9.6k | 0% | Dec 2023 |
|
| BFSG | 2.0k | $9.1k | 100% | Dec 2023 |
|
| Us Bancorp | 1.2k | $5.3k | 0% | Dec 2023 |
|
| Cutler | 400.00 | $1.0k | 0% | Dec 2023 |
|
| Tennessee Valley Asset Management Partners | 8.00 | $36.000000 | 100% | Dec 2023 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Larimar Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Connor, Clark & Lunn Investment Management | Sep 2023 | 22k | $86k |
| Advisor Group Holdings | Sep 2023 | 1.0k | $4.0k |